Literature DB >> 26598569

Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

Casey L McAtee1, Rachel Webman2, Robert H Gilman2, Carolina Mejia2, Caryn Bern2, Sonia Apaza2, Susan Espetia2, Mónica Pajuelo2, Mayuko Saito2, Roxanna Challappa2, Richard Soria2, Jose P Ribera2, Daniel Lozano2, Faustino Torrico2.   

Abstract

The effectiveness of rotavirus vaccine in the field may set the stage for a changing landscape of diarrheal illness affecting children worldwide. Norovirus and rotavirus are the two major viral enteropathogens of childhood. This study describes the prevalence of norovirus and rotavirus 2 years after widespread rotavirus vaccination in Cochabamba, Bolivia. Stool samples from hospitalized children with acute gastroenteritis (AGE) and outpatients aged 5-24 months without AGE were recruited from an urban hospital serving Bolivia's third largest city. Both viruses were genotyped, and norovirus GII.4 was further sequenced. Norovirus was found much more frequently than rotavirus. Norovirus was detected in 69/201 (34.3%) of specimens from children with AGE and 13/71 (18.3%) of those without diarrhea. Rotavirus was detected in 38/201 (18.9%) of diarrheal specimens and 3/71 (4.2%) of non-diarrheal specimens. Norovirus GII was identified in 97.8% of norovirus-positive samples; GII.4 was the most common genotype (71.4% of typed specimens). Rotavirus G3P[8] was the most prevalent rotavirus genotype (44.0% of typed specimens) and G2P[4] was second most prevalent (16.0% of typed specimens). This community is likely part of a trend toward norovirus predominance over rotavirus in children after widespread vaccination against rotavirus. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26598569      PMCID: PMC4710432          DOI: 10.4269/ajtmh.15-0203

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  39 in total

1.  Genogroup-specific PCR primers for detection of Norwalk-like viruses.

Authors:  Shigeyuki Kojima; Tsutomu Kageyama; Shuetsu Fukushi; Fuminori B Hoshino; Michiyo Shinohara; Kazue Uchida; Katsuro Natori; Naokazu Takeda; Kazuhiko Katayama
Journal:  J Virol Methods       Date:  2002-02       Impact factor: 2.014

2.  Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.

Authors:  Alexandre C Linhares; F Raúl Velázquez; Irene Pérez-Schael; Xavier Sáez-Llorens; Hector Abate; Felix Espinoza; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Doris Maribel Rivera-Medina; Luis Rivera; Noris Pavía-Ruz; Ernesto Nuñez; Silvia Damaso; Guillermo M Ruiz-Palacios; Béatrice De Vos; Miguel O'Ryan; Paul Gillard; Alain Bouckenooghe
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

3.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Authors:  V Gouvea; R I Glass; P Woods; K Taniguchi; H F Clark; B Forrester; Z Y Fang
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.

Authors:  Beatrice De Vos; Htay Htay Han; Alain Bouckenooghe; Serge Debrus; Paul Gillard; Richard Ward; Brigitte Cheuvart
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129

5.  Norovirus highly prevalent cause of endemic acute diarrhea in children in the peruvian Amazon.

Authors:  Pablo Peñataro Yori; Kellogg Schwab; Robert H Gilman; Sharon Nappier; Daniel Velasquez Portocarrero; Robert E Black; Maribel Paredes Olortegui; Eric R Hall; Christine Moe; Juan Leon; Vita A Cama; Margaret Kosek
Journal:  Pediatr Infect Dis J       Date:  2009-09       Impact factor: 2.129

Review 6.  [WHO growth standards for infants and young children].

Authors:  M de Onis; C Garza; A W Onyango; M-F Rolland-Cachera
Journal:  Arch Pediatr       Date:  2008-11-25       Impact factor: 1.180

7.  Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.

Authors:  Jailson B Correia; Manish M Patel; Osamu Nakagomi; Fernanda M U Montenegro; Eliane M Germano; Nancy B Correia; Luis E Cuevas; Umesh D Parashar; Nigel A Cunliffe; Toyoko Nakagomi
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

8.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.

Authors:  T Ruuska; T Vesikari
Journal:  Scand J Infect Dis       Date:  1990

9.  Diagnosing norovirus-associated infectious intestinal disease using viral load.

Authors:  Gemma Phillips; Ben Lopman; Clarence C Tam; Miren Iturriza-Gomara; David Brown; Jim Gray
Journal:  BMC Infect Dis       Date:  2009-05-14       Impact factor: 3.090

Review 10.  Systematic literature review of role of noroviruses in sporadic gastroenteritis.

Authors:  Manish M Patel; Marc-Alain Widdowson; Roger I Glass; Kenichiro Akazawa; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  19 in total

Review 1.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

2.  Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.

Authors:  Wen Dang; Yuebang Yin; Yijin Wang; Wenshi Wang; Junhong Su; Dave Sprengers; Luc J W van der Laan; Krzysztof Felczak; Krzysztof W Pankiewicz; Kyeong-Ok Chang; Marion P G Koopmans; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Adapting Syndromic Surveillance Baselines After Public Health Interventions.

Authors:  Roger Antony Morbey; Alex James Elliot; Gillian Elizabeth Smith; Andre Charlett
Journal:  Public Health Rep       Date:  2020-10-07       Impact factor: 2.792

4.  Norovirus prevalence and estimated viral load in symptomatic and asymptomatic children from rural communities of Vhembe district, South Africa.

Authors:  Jean Pierre Kabue; Emma Meader; Paul R Hunter; Natasha Potgieter
Journal:  J Clin Virol       Date:  2016-09-13       Impact factor: 3.168

Review 5.  Significance of continuous rotavirus and norovirus surveillance in Indonesia.

Authors:  Mohamad Saifudin Hakim; Hera Nirwati; Abu Tholib Aman; Yati Soenarto; Qiuwei Pan
Journal:  World J Pediatr       Date:  2018-02-14       Impact factor: 2.764

6.  Norovirus and Other Viral Causes of Medically Attended Acute Gastroenteritis Across the Age Spectrum: Results from the Medically Attended Acute Gastroenteritis Study in the United States.

Authors:  Rachel M Burke; Claire P Mattison; Zachary Marsh; Kayoko Shioda; Judy Donald; S Bianca Salas; Allison L Naleway; Christianne Biggs; Mark A Schmidt; Aron J Hall
Journal:  Clin Infect Dis       Date:  2021-08-16       Impact factor: 20.999

7.  Pediatric norovirus GII.4 infections in Nicaragua, 1999-2015.

Authors:  Filemón Bucardo; Yaoska Reyes; Sylvia Becker-Dreps; Natalie Bowman; Joann F Gruber; Jan Vinjé; Felix Espinoza; Margarita Paniagua; Angel Balmaseda; Lennart Svensson; Johan Nordgren
Journal:  Infect Genet Evol       Date:  2017-10-02       Impact factor: 3.342

8.  Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.

Authors:  Gabriel I Parra; R Burke Squires; Consolee K Karangwa; Jordan A Johnson; Cara J Lepore; Stanislav V Sosnovtsev; Kim Y Green
Journal:  PLoS Pathog       Date:  2017-01-19       Impact factor: 6.823

9.  Experimental Methods to Study the Pathogenesis of Human Enteric RNA Viruses.

Authors:  Somya Aggarwal; Ebrahim Hassan; Megan T Baldridge
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

10.  Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Boyd Yount; Matthew H Collins; Kari Debbink; Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.